European Heart Journal

دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه

ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
~~قیمت : 3,800,000 تومان~~
قیمت ویژه : 1,900,000تومان

سفارش

Challenges and opportunities in the management of acute heart failure and cardiac amyloidosis

Filippo Crea

doi : 10.1093/eurheartj/ehad403

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2135â€“2139

خرید پکیج و مشاهده آنلاین مقاله

Rediscovery of magnetocardiography for diagnostic screening and monitoring of treatment response in cardiology

Bettina Heidecker

doi : 10.1093/eurheartj/ehad213

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2140â€“2142

خرید پکیج و مشاهده آنلاین مقاله

Call for participation in the AtheroNET COST Action to implement multiomics in atherosclerotic cardiovascular disease research

Miron Sopic, Georgios Kararigas, Yvan Devaux, Paolo Magni

doi : 10.1093/eurheartj/ehad153

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2143â€“2145

خرید پکیج و مشاهده آنلاین مقاله

Reviewers List 2022

doi : 10.1093/eurheartj/ehad157

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2146â€“2156

خرید پکیج و مشاهده آنلاین مقاله

Intravascular imaging to guide percutaneous coronary intervention of complex lesions: time to renovate guidelines?

Rocco Vergallo, Giovanna Liuzzo

doi : 10.1093/eurheartj/ehad243

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2157â€“2158

خرید پکیج و مشاهده آنلاین مقاله

Great debate: in patients with decompensated heart failure, acetazolamide in addition to loop diuretics is the first choice

Wilfried Mullens, Paul Christian Schulze, Julian Westphal, JÃ¼rgen Bogoviku, Johann Bauersachs

doi : 10.1093/eurheartj/ehad266

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2159â€“2169

خرید پکیج و مشاهده آنلاین مقاله

Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER

Jawad H Butt, Toru Kondo, Mingming Yang, Pardeep S Jhund, Kieran F Docherty, Muthiah Vaduganathan, Brian L Claggett, Adrian F Hernandez, Carolyn S P Lam, Silvio E Inzucchi, Felipe A Martinez, Rudolf A de Boer, Mikhail N Kosiborod, Akshay S Desai, Lars KÃ¸ber, Piotr Ponikowski, Marc S Sabatine, Sanjiv J Shah, Natalia Zaozerska, Ulrica WilderÃ¤ng, Olof Bengtsson, Scott D Solomon, John J V McMurray

doi : 10.1093/eurheartj/ehad276

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2170â€“2183

Because an increased risk of amputation with canagliflozin was reported in the CANVAS trials, there has been a concern about the safety of sodiumâ€“glucose cotransporter 2 inhibitors in patients with peripheral artery disease (PAD) who are at higher risk of amputation.

خرید پکیج و مشاهده آنلاین مقاله

Good for your heart and safe for your toes: a patient-level meta-analysis of DAPA-HF and DELIVER

Clare Arnott, Bruce Neal

doi : 10.1093/eurheartj/ehad315

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2184â€“2186

خرید پکیج و مشاهده آنلاین مقاله

Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis

Muhammad Umaid Rauf, Philip N Hawkins, Francesco Cappelli, Federico Perfetto, Mattia Zampieri, Alessia Argiro, Aviva Petrie, Steven Law, Aldostefano Porcari, Yousuf Razvi, Joshua Bomsztyk, Sriram Ravichandran, Adam Ioannou, Rishi Patel, Neasa Starr, David F Hutt, Shameem Mahmood, Brendan Wisniowski, Ana Martinezâ€“Naharro, Lucia Venneri, Carol Whelan, Dorota Roczenio, Janet Gilbertson, Helen J Lachmann, Ashutosh D Wechalekar, Claudio Rapezzi, Matteo Serenelli, Paolo Massa, Angelo Giuseppe Caponetti, Alberto Ponziani, Antonella Accietto, Alessandro Giovannetti, Giulia Saturi, Maurizio Sguazzotti, Christian Gagliardi, Elena Biagini, Simone Longhi, Marianna Fontana, Julian D Gillmore

doi : 10.1093/eurheartj/ehad139

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2187â€“2198

To perform evaluation of widely embraced bone scintigraphy-based non-biopsy diagnostic criteria (NBDC) for ATTR amyloid cardiomyopathy (ATTR-CM) in clinical practice, and to refine serum free light chain (sFLC) ratio cut-offs that reliably exclude monoclonal gammopathy (MG) in chronic kidney disease.

خرید پکیج و مشاهده آنلاین مقاله

Expanding indications for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy

Sharmila Dorbala

doi : 10.1093/eurheartj/ehad281

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2199â€“2201

خرید پکیج و مشاهده آنلاین مقاله

Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial

Paolo Tolomeo, Jawad H Butt, Toru Kondo, Gianluca Campo, Akshay S Desai, Pardeep S Jhund, Lars KÃ¸ber, Martin P Lefkowitz, Jean L Rouleau, Scott D Solomon, Karl Swedberg, Muthiah Vaduganathan, Michael R Zile, Milton Packer, John J V McMurray

doi : 10.1093/eurheartj/ehad210

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2202â€“2212

The 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation combining creatinine and cystatin C provides a better estimation of glomerular filtration rate (GFR) compared to the creatinine-only equation.

خرید پکیج و مشاهده آنلاین مقاله

Risk of knowing too much: the tricky case of estimated glomerular filtration rate and treatment decisions in heart failure

Kevin Damman

doi : 10.1093/eurheartj/ehad284

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2213â€“2215

خرید پکیج و مشاهده آنلاین مقاله

Sodiumâ€“glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study

Edouard L Fu, Elisabetta Patorno, Brendan M Everett, Muthiah Vaduganathan, Scott D Solomon, Raisa Levin, Sebastian Schneeweiss, Rishi J Desai

doi : 10.1093/eurheartj/ehad273

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2216â€“2230

The effectiveness of sodiumâ€“glucose cotransporter 2 inhibitors (SGLT2i) in patients with heart failure (HF) in routine clinical practice is not extensively studied. This study aimed to evaluate the comparative effectiveness of SGLT2i vs.

خرید پکیج و مشاهده آنلاین مقاله

SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world

Nikolaus Marx, Dirk MÃ¼ller-Wieland

doi : 10.1093/eurheartj/ehad282

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2231â€“2233

خرید پکیج و مشاهده آنلاین مقاله

COVID-19 vaccination-related myocarditis: a Korean nationwide study

Jae Yeong Cho, Kye Hun Kim, Nuri Lee, Soo Hyeon Cho, Seung Yun Kim, Eun Kyoung Kim, Jae-Hyeong Park, Eui-Young Choi, Jin-Oh Choi, Hyukjin Park, Hyung Yoon Kim, Hyun Ju Yoon, Youngkeun Ahn, Myung Ho Jeong, Jeong Gwan Cho

doi : 10.1093/eurheartj/ehad339

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2234â€“2243,

A comprehensive nationwide study on the incidence and outcomes of COVID-19 vaccination-related myocarditis (VRM) is in need.

خرید پکیج و مشاهده آنلاین مقاله

Takotsubo syndrome is a coronary microvascular disease: experimental evidence

Feng Dong, Liya Yin, Hamayak Sisakian, Tatevik Hakobyan, Lacey S Jeong, Hirva Joshi, Ellianna Hoff, Selena Chandler, Geetika Srivastava, Abdur Rahman Jabir, Kelly Kimball, Yeong-Renn Chen, Chwen-Lih Chen, Patrick T Kang, Parisa Shabani, Lindsay Shockling, Thomas Pucci, Karlina Kegecik, Christopher Kolz, Zhenyu Jia, William M Chilian, Vahagn Ohanyan

doi : 10.1093/eurheartj/ehad274

European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2244â€“2253

Takotsubo syndrome (TTS) is a conundrum without consensus about the cause. In a murine model of coronary microvascular dysfunction (CMD), abnormalities in myocardial perfusion played a key role in the development of TTS.

خرید پکیج و مشاهده آنلاین مقاله